Skip to main content
Login
Contact
E-Edition
Subscribe
Search form
Search
The Newport Daily Express
Click for weather forecast
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
324.71
+0.48 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 1, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Week In Review: Henlius Signs $196 Million Deal For Two Oncology Bifunctional Sialidase Candidates
July 02, 2022
Shanghai Henlius Biotech acquired Greater China rights to two early-stage bifunctional sialidase candidates from Palleon Pharma, a Waltham, MA biopharma, in a deal with $196.5 million in development...
Via
Talk Markets
What Are Whales Doing With Eli Lilly
July 01, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 14 strange trades.
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $400 Today
June 29, 2022
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 21.93% on an annualized basis producing an average annual return of 31.32%. Currently, Eli Lilly has a market capitalization of...
Via
Benzinga
Sanofi Lowers Out-Of-Pocket Insulin Cost For Uninsured Patients
June 29, 2022
Via
Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
June 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock
June 17, 2022
Via
Benzinga
5 S&P 500 Stocks Ready to Break Out
June 29, 2022
Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out.
Via
InvestorPlace
Check Out What Whales Are Doing With LLY
June 28, 2022
Someone with a lot of money to spend has taken a bearish stance on Eli Lilly (NYSE:LLY). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
7 Defensive Stocks to Buy for a Bear Market
June 27, 2022
As Wall Street gets ready for another earnings season, investors are increasingly chasing after defensive stocks to buy for a bear market.
Via
InvestorPlace
From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid
June 27, 2022
More than four in 10 people in a recent survey knew of someone with long Covid.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Executives Sell More Than $67M Of 5 Stocks: NetApp, Eli Lilly And More
June 24, 2022
US gold futures traded lower on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
This Is What Whales Are Betting On Eli Lilly
June 23, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 17 strange trades.
Via
Benzinga
Bear Market Rally Lifts HealthCare Stocks Off Bottom
June 22, 2022
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
Via
Talk Markets
Peering Into Eli Lilly's Recent Short Interest
June 16, 2022
Eli Lilly's (NYSE:LLY) short percent of float has risen 4.76% since its last report. The company recently reported that it has 5.23 million shares sold short, which is 0.66% of...
Via
Benzinga
Jim Cramer Says This Company Is A Great One
June 16, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield.
Via
Benzinga
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
June 14, 2022
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $5,000 Today
June 14, 2022
Eli Lilly (NYSE:LLY) has outperformed the market over the past 15 years by 5.21% on an annualized basis producing an average annual return of 11.42%. Currently, Eli Lilly has a market capitalization of...
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
June 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Tuesday, June 14
June 14, 2022
CNBC
Via
Benzinga
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
June 14, 2022
Alopecia areata, an autoimmune disorder that causes patchy hair loss, now has a new treatment that has been approved by the Food and Drug Administration.
Via
Benzinga
Looking At Eli Lilly's Recent Whale Trades
June 10, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 35 strange trades.
Via
Benzinga
Stock Market Rally Under Pressure As Indexes Tumble, Breakouts Fail: Weekly Review
June 10, 2022
The 10-year Treasury yield soared above 3% as inflation came in hot.
Via
Investor's Business Daily
7 Great ETFs to Buy Now for Momentum in Q2
June 10, 2022
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments.
Via
InvestorPlace
CNBC's Final Trades: Sabra Health Care, Eli Lilly, FedEx And This Way To Gain EV Exposure
June 10, 2022
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT Inc (NASDAQ: SBRA) has an 8.5% yield an
Via
Benzinga
We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit
June 10, 2022
The conversation around obesity is changing. Two diabetes drug makers are at the forefront.
Via
Investor's Business Daily
6 Stocks Moved By Traders On 'Fast Money Halftime Report'
June 09, 2022
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned....
Via
Benzinga
Don't Trade This Stock Market
June 09, 2022
Stocks and the stock market as a whole have traded sideways for the past eight trading sessions. What will be the next big move that the stock market makes?
Via
Talk Markets
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
June 08, 2022
Image provided by Pexels
Via
Benzinga
In Eli Lilly's Lebrikizumab Atopic Dermatitis Study, Majority Of Patients Maintained Skin Clearance At One Year
June 07, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.